MedCap AB (publ) (STO:MCAP)
Sweden · Delayed Price · Currency is SEK 463.00
+4.00 (0.87%)
Mar 24, 2026, 4:00 PM CET
MedCap AB Market Cap
MedCap AB has a market cap or net worth of 6.89 billion as of March 24, 2026. Its market cap has increased by 22.61% in one year.
Market Cap
6.89B
Enterprise Value
7.01B
Revenue
2.11B
Ranking
n/a
PE Ratio
31.29
Stock Price
463.00
Market Cap Chart
Since July 4, 2006, MedCap AB's market cap has increased from 37.25M to 6.89B, an increase of 18,407.91%. That is a compound annual growth rate of 30.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 6.89B | -16.72% |
| Dec 30, 2025 | 8.28B | -6.99% |
| Dec 30, 2024 | 8.90B | 78.07% |
| Dec 29, 2023 | 5.00B | 55.89% |
| Dec 30, 2022 | 3.21B | 21.63% |
| Dec 30, 2021 | 2.64B | -22.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 49.19B |
| Sectra AB | 42.77B |
| Elekta AB | 21.51B |
| Nolato AB | 12.74B |
| Vitrolife AB | 11.91B |
| Xvivo Perfusion AB | 5.76B |
| CellaVision AB | 3.43B |
| BICO Group AB | 1.18B |